东亚与欧洲人群大规模荟萃分析更新类风湿关节炎遗传架构并识别11个新易感位点
研究识别出11个新的类风湿关节炎易感位点,分别解释东亚人和欧洲人6.9%和1.8%的SNP遗传力,并确认71个已知非HLA易感位点、90个独立关联信号。
要点
- 新发现11个RA易感位点,解释东亚人6.9%、欧洲人1.8%的SNP遗传力。
- 确认71个已知非HLA位点,共识别90个独立关联信号。
- RA变异富集于转录因子结合位点和细胞类型特异性转录激活组蛋白标记。
核心结论
- 研究更新了类风湿关节炎的遗传架构,识别11个新易感位点并确认71个已知非HLA位点,为变异驱动的发病机制提供线索。
研究设计与样本
- 利用公共组学资源开展多种计算分析,以优先排序因果变异和基因、RA变异涉及的特征及潜在可重定位药物。
主要发现
- 11个新RA易感位点分别解释东亚人和欧洲人6.9%和1.8%的SNP遗传力。
- 确认71个已知非HLA易感位点,识别90个独立关联信号。
- RA变异优先位于多种转录因子结合位点和细胞类型特异性转录激活组蛋白标记中,同时提示CD4+ T细胞活化的重要性及非免疫器官在RA发病中的潜在作用。
- 基于基因关联、表达相关变异和染色质相互作用,共获得615个可能的效应基因,包括已批准RA治疗药物的靶点和潜在可重定位的其他适应症药物。
临床怎么用
- 研究识别的615个可能效应基因包含已批准RA药物靶点及潜在可重定位药物,可为RA治疗药物选择或重定位提供遗传学线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Nearly 110 susceptibility loci for rheumatoid arthritis (RA) with modest effect sizes have been identified by population-based genetic association studies, suggesting a large number of undiscovered variants behind a highly polygenic genetic architecture of RA. Here, we performed the largest-ever trans-ancestral meta-analysis with the aim to identify new RA loci and to better understand RA biology underlying genetic associations. METHODS: Genome-wide RA association summary statistics in three large case-control collections consisting of 311 292 individuals of Korean, Japanese and European populations were used in an inverse-variance-weighted fixed-effects meta-analysis. Several computational analyses using public omics resources were conducted to prioritise causal variants and genes, RA variant-implicating features (tissues, pathways and transcription factors) and potentially repurposable drugs for RA treatment. RESULTS: We identified 11 new RA susceptibility loci that explained 6.9% and 1.8% of the single-nucleotide polymorphism-based heritability in East Asians and Europeans, respectively, and confirmed 71 known non-human leukocyte antigens (HLA) susceptibility loci, identifying 90 independent association signals. The RA variants were preferentially located in binding sites of various transcription factors and in cell type-specific transcription-activation histone marks that simultaneously highlighted the importance of CD4+ T-cell activation and the potential role of non-immune organs in RA pathogenesis. A total of 615 plausible effector genes, based on gene-based associations, expression-associated variants and chromatin interaction, included targets of drugs approved for RA treatments and potentially repurposable drugs approved for other indications. CONCLUSION: Our findings provide useful insights regarding RA genetic aetiology and variant-driven RA pathogenesis.
引用
- Ha E, Bae SC, Kim K, et al. Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann Rheum Dis. 2020. PMID: 33310728. doi:10.1136/annrheumdis-2020-219065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。